We just received data on a new analyst forecast for $TRVI. Judah Frommer from Morgan Stanley set a price target of 18.0 for TRVI.
To track analyst ratings and price targets for $TRVI, check out Quiver Quantitative's $TRVI forecast page.
$TRVI Price Targets
Multiple analysts have issued price targets for $TRVI recently. We have seen 9 analysts offer price targets for $TRVI in the last 6 months, with a median target of $21.0.
Here are some recent targets:
- Judah Frommer from Morgan Stanley set a target price of $18.0 on 08/21/2025
- Ryan Deschner from Raymond James set a target price of $27.0 on 08/08/2025
- Serge Belanger from Needham set a target price of $22.0 on 08/08/2025
- Josh Schimmer from Cantor Fitzgerald set a target price of $25.0 on 07/01/2025
- Jason Kolbert from D. Boral Capital set a target price of $21.0 on 06/02/2025
- Brandon Folkes from HC Wainwright & Co. set a target price of $21.0 on 05/28/2025
- Mayank Mamtani from B. Riley Securities set a target price of $20.0 on 03/19/2025
$TRVI Insider Trading Activity
$TRVI insiders have traded $TRVI stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $TRVI stock by insiders over the last 6 months:
- FARRELL SIMON (Chief Commercial Officer) has made 0 purchases and 2 sales selling 81,313 shares for an estimated $548,877.
- JENNIFER L GOOD (President & CEO) sold 5,263 shares for an estimated $34,624
- THOMAS SCIASCIA (Chief Scientific Officer) sold 2,631 shares for an estimated $17,364
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$TRVI Hedge Fund Activity
We have seen 102 institutional investors add shares of $TRVI stock to their portfolio, and 66 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ALLIANCEBERNSTEIN L.P. added 4,259,015 shares (+19064.5%) to their portfolio in Q2 2025, for an estimated $23,296,812
- RUBRIC CAPITAL MANAGEMENT LP added 3,993,325 shares (+88.0%) to their portfolio in Q2 2025, for an estimated $21,843,487
- ARMISTICE CAPITAL, LLC removed 2,988,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $16,344,360
- BLACKROCK, INC. added 2,892,464 shares (+54.4%) to their portfolio in Q2 2025, for an estimated $15,821,778
- ORBIMED ADVISORS LLC added 2,188,400 shares (+195.4%) to their portfolio in Q2 2025, for an estimated $11,970,548
- WOODLINE PARTNERS LP added 1,988,623 shares (+96.6%) to their portfolio in Q2 2025, for an estimated $10,877,767
- NEA MANAGEMENT COMPANY, LLC added 1,851,852 shares (+16.3%) to their portfolio in Q2 2025, for an estimated $10,129,630
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
